Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,626 INR | +1.74% | +3.02% | +1.88% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.88% | 2.57B | |
-23.07% | 8.1B | |
+65.14% | 4.26B | |
-8.06% | 2.49B | |
-40.47% | 2.39B | |
-12.98% | 1.77B | |
-21.01% | 1.53B | |
+16.01% | 1.2B | |
-42.17% | 1.18B | |
+14.78% | 956M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024